Novel method for diagnosing pregnancy-related complications
AssigneeDiagnostic Technologies Ltd.
InventorsHamutal Meiri, Marei Sammar, Moran Sade
Life of this patent
Estimating the term…
Abstract
A method for diagnosing pregnancy-related complications in a pregnant woman is provided. The method includes the following steps: (a) determining the level of Placental Protein 17 (PP17) in a bodily substance obtained from the pregnant woman; and (b) comparing the determined level of PP17 to a standard level of PP17, a significant modification in the level of PP17 indicating the existence of a pregnancy-related complication in the pregnant woman. A diagnostic kit is also described.
Claims12
A method for diagnosing pregnancy-related complications in a pregnant woman, comprising:
- (a) determining a level of Placental Protein 17 (PP17) in a bodily substance obtained from the pregnant woman;
- and
- (b) comparing the determined level of PP17 to a standard level of PP17, a significant increase in the level of PP17 indicating the existence of a pregnancy-related complication in the pregnant woman.
A kit for diagnosing pregnancy-related complications in a pregnant woman, comprising:
- (a) a first antibody which specifically binds to PP17;
- (b) a second antibody which specifically binds to PP17 linked to a signal-generating molecule;
- and
- (c) PP17 standard solutions.
A kit for diagnosing pregnancy-related complications in a pregnant woman, comprising:
- (a) specific PP17 primers;
- and
- (b) positive and negative cDNA controls.
Dependencies are inferred from the claim text.